I reported previously (Jun 5) that Israel’s Collplant was developing a bio-ink that could 3D print tissues and organs. Collplant has now setup a division to produce the ink, which could eventually be the answer for patients desperately waiting for … Continue reading →

Israel’s CollPlant has been awarded the EU CE Mark for VergenixSTR, a soft tissue repair matrix for the treatment of tendinopathy (tendon injury or disease and associated pain).  VergenixSTR is based on CollPlant’s proprietary plant-based collagen technology. http://www.globes.co.il/en/article-collplant-awarded-eu-ce-mark-for-tendinopathy-treatment-1001156788

Israel’s Collplant has reported positive results of trials of its Vergenix STR treatment for inflammation of the elbow tendon – commonly referred to as tennis elbow.  Most of the 40 patients reported less pain and disability – far better than … Continue reading →

Israel’s Chief Scientist has awarded NIS 5.6 million to Israel’s Collplant.  It will help finance projects, including the development of plant-based collagen and formulations intended for use as BioInk for 3D printing of tissues and organs. http://www.globes.co.il/en/article-collplant-awarded-bio-ink-grant-for-3d-organ-tissue-printing-1001128604

(Thanks to Atid-EDI) Israeli health organization Maccabi is to commence trials of the Vergenix flowable gel developed by Israel’s CollPlant. Two Maccabi wound clinics will use Vergenix to treat patients with chronic leg ulcers. Vergenix is based on CollPlant’s plant-based … Continue reading →

Israel’s Collplant has signed an agreement with Pfizer to jointly develop an orthopaedic product for the repair of compound fractures. Collplant manufactures human collagen from plants. http://www.globes.co.il/serveen/globes/docview.asp?did=1000709584&fid=1725 http://www.youtube.com/watch?v=6W8UVanYyLM